[1]
R. Magistroni, “Tolvaptan: Clinical Evidence for Slowing the Progression of Autosomal Dominant Polycystic Kidney Disease”, G Clin Nefrol Dial, vol. 29, no. 2, pp. 80–84, May 2017.